The International Vaccine Institute, the only international organization headquartered in Korea, announced July 2 that its Board of Trustees (BOT) approved the reappointment of Director John D. Clemens (55).
"The IVI has made great strides under Dr. John Clemens´ leadership," said Prof. Sam Katz, chairman of the IVI Board of Trustees, upon the completion of its two-day annual BOT meeting. "The board has decided to let him continue to lead IVI´s scientific mission and activities for the development and introduction of new vaccines for children for the next five years."
Dr John D. Clemens, who started his first term of office in July 1999, has been spearheading dynamic growth of the institute for the past five years. In 2000, he succeeded in winning a $40 million grant from the Bill and Melinda Gates Foundation for the Diseases of Most Impoverished (DOMI) program. Dr Clemens also succeed in creating the pediatric Dengue Vaccine Initiative (PDVI), a coalition to accelerate the development and introduction of dengue vaccines for children, which recently received an additional $55 million-grant from the Gates Foundation.
"Despite the achievements we have made, we are still in an expansionary mode. We will not only broaden the diseases of our scientific research to cover Tuberculosis and respiratory viruses, but we will also be expanding the geographic scope of our activities to sub-Saharan Africa," Dr. Clemens said.
This year, the Institute has just kick-started laboratory research at its new state-of-the-art-laboratories to develop promising next generation vaccines, including vaccines against shigellosis and typhoid fever. "The launch of the laboratory program is expected to synergize with our field research programs in developing countries," Dr. Clemens noted.
John D. Clemens, M.D.
John D. Clemens, M.D., Director, began his first five-year term on July 1, 1999. Dr. Clemens is an international expert on vaccine evaluation in developing countries. He is a graduate of Stanford University and Yale University School of Medicine. For five years, Dr. Clemens was a Research Scientist at the International Center for Diarrheal Disease Research, Bangladesh. Before joining the International Vaccine Institute, he held senior positions at the United States National Institute of Health, where he was Chief of the Epidemiology Branch and Chief of the Section on Pediatric Infectious Diseases and Vaccinology of the National Institute of Child Health and Human Development. He has been a long-term advisor to the WHO and is Director of the WHO Collaborating Center for Clinical Evaluation of Vaccines in Developing Countries. He has a continuing appointment as an adjunct professor at Johns Hopkins University. Dr. Clemens has successfully undertaken numerous vaccine research projects in developing countries. His past research in Asia has included projects in Bangladesh, India, Indonesia, and Vietnam. He has published over 150 papers in peer-reviewed journals and is an expert both on vaccines against enteric infections and on methodological approaches for vaccine evaluations. He has pioneered methods for the conceptualization, design, implementation, and evaluation of effectiveness trials of new vaccines.